Miromatrix Medical Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Miromatrix Medical Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2023.
  • Miromatrix Medical Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$6.45M, a 15.4% increase year-over-year.
  • Miromatrix Medical Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$27.4M, a 3.79% increase year-over-year.
  • Miromatrix Medical Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$30M, a 104% decline from 2021.
  • Miromatrix Medical Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.7M, a 42.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$27.4M -$6.45M +$1.17M +15.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$28.6M -$6.53M +$1.65M +20.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$30.2M -$7.48M -$276K -3.84% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$30M -$6.95M -$1.47M -26.8% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$28.5M -$7.63M -$2.57M -50.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$25.9M -$8.18M -$4.48M -121% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$21.4M -$7.2M -$6.77M -1559% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$14.7M -$5.48M -$4.39M -403% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$10.3M -$5.06M -$2.07M -69% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.22M -$3.7M -$430K -13.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$7.79M -$434K +$2.52M +85.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$10.3M -$1.09M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$2.99M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.27M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$2.96M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.